These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20410194)

  • 1. The corn protein, zein hydrolysate, administered into the ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats.
    Mochida T; Hira T; Hara H
    Endocrinology; 2010 Jul; 151(7):3095-104. PubMed ID: 20410194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLP-1 secretion is enhanced directly in the ileum but indirectly in the duodenum by a newly identified potent stimulator, zein hydrolysate, in rats.
    Hira T; Mochida T; Miyashita K; Hara H
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G663-71. PubMed ID: 19661152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of corn zein hydrolysate stimulates GLP-1 and GIP secretion and improves glucose tolerance in male normal rats and Goto-Kakizaki rats.
    Higuchi N; Hira T; Yamada N; Hara H
    Endocrinology; 2013 Sep; 154(9):3089-98. PubMed ID: 23798598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rice protein hydrolysates stimulate GLP-1 secretion, reduce GLP-1 degradation, and lower the glycemic response in rats.
    Ishikawa Y; Hira T; Inoue D; Harada Y; Hashimoto H; Fujii M; Kadowaki M; Hara H
    Food Funct; 2015 Aug; 6(8):2525-34. PubMed ID: 26107658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular fraction of wheat protein hydrolysate stimulates glucagon-like peptide-1 secretion in an enteroendocrine L cell line and improves glucose tolerance in rats.
    Kato M; Nakanishi T; Tani T; Tsuda T
    Nutr Res; 2017 Jan; 37():37-45. PubMed ID: 28215313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition.
    Chang E; Kim L; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park DI; Park CY
    Metabolism; 2015 May; 64(5):633-41. PubMed ID: 25704082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of glycemic control in streptozotocin-induced diabetic rats by Atlantic salmon skin gelatin hydrolysate as the dipeptidyl-peptidase IV inhibitor.
    Hsieh CH; Wang TY; Hung CC; Chen MC; Hsu KC
    Food Funct; 2015 Jun; 6(6):1887-92. PubMed ID: 25946069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLP-1 secretion in response to oral and luminal palatinose (isomaltulose) in rats.
    Hira T; Muramatsu M; Okuno M; Hara H
    J Nutr Sci Vitaminol (Tokyo); 2011; 57(1):30-5. PubMed ID: 21512288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bis-Pyrano Prenyl Isoflavone Improves Glucose Homeostasis by Inhibiting Dipeptidyl Peptidase-4 in Hyperglycemic Rats.
    Altenhofen D; da Luz G; Frederico MJ; Venzke D; Brich M; Vigil S; Fröde TS; Linares CE; Pizzolatti MG; Silva FR
    J Cell Biochem; 2017 Jan; 118(1):92-103. PubMed ID: 27238050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
    Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
    Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive increase in active GLP-1 levels by the DPP4 inhibitor ASP4000 on a new meal tolerance test in Zucker fatty rats.
    Tanaka-Amino K; Hatakeyama Y; Takakura S; Mutoh S
    Pharmacol Res; 2009 Oct; 60(4):264-9. PubMed ID: 19520592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical and pharmacological properties of glucagon-like peptide-1 in rats under isoflurane anesthesia.
    Kawano T; Tanaka K; Chi H; Eguchi S; Yamazaki F; Kitamura S; Kumagai N; Yokoyama M
    Anesth Analg; 2012 Jul; 115(1):62-9. PubMed ID: 22504208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents.
    Oguma T; Nakayama K; Kuriyama C; Matsushita Y; Yoshida K; Hikida K; Obokata N; Tsuda-Tsukimoto M; Saito A; Arakawa K; Ueta K; Shiotani M
    J Pharmacol Exp Ther; 2015 Sep; 354(3):279-89. PubMed ID: 26105952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent effect of glucose on GLP-1 secretion involves sweet taste receptor in isolated perfused rat ileum [Rapid Communication].
    Xu Z; Wang W; Nian X; Song G; Zhang X; Xiao H; Zhu X
    Endocr J; 2016 Dec; 63(12):1141-1147. PubMed ID: 27853059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum.
    Dumoulin V; Moro F; Barcelo A; Dakka T; Cuber JC
    Endocrinology; 1998 Sep; 139(9):3780-6. PubMed ID: 9724030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nondigestible saccharide, fructooligosaccharide, increases the promotive effect of a flavonoid, α-glucosyl-isoquercitrin, on glucagon-like peptide 1 (GLP-1) secretion in rat intestine and enteroendocrine cells.
    Phuwamongkolwiwat P; Hira T; Hara H
    Mol Nutr Food Res; 2014 Jul; 58(7):1581-4. PubMed ID: 24753209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations.
    Fukuda-Tsuru S; Anabuki J; Abe Y; Yoshida K; Ishii S
    Eur J Pharmacol; 2012 Dec; 696(1-3):194-202. PubMed ID: 23022337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between anagliptin concentration showing over 80% inhibition of plasma dipeptidyl peptidase-4 activity and its protective effect against glucagon-like peptide-1 degradation.
    Furuta S; Goto M; Tamura M; Yamashita S; Nakaya K; Furuta Y
    Drug Res (Stuttg); 2014 Mar; 64(3):130-5. PubMed ID: 23965798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats.
    Balkan B; Kwasnik L; Miserendino R; Holst JJ; Li X
    Diabetologia; 1999 Nov; 42(11):1324-31. PubMed ID: 10550416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
    Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.